01. COVID-19 Antigen Schnelltest (Colloidal Gold) wanda Kamfanin Joinstar Biomedical Technology ya haɓaka ya sami tabbacin aikin daga cibiyar Paul Ehrlich. Tare da Abbott, Roche, SD, BD, Siemens LumiraDX, da sauran shahararrun kamfanoni na duniya, Joinstar Biomedical Technology ya zama ɗayan manufacturersan masana'antun antigen da PEI ta amince da su a rukunin farko a duniya.

nongsuotu

"Paul-ehrlich-institut" (PEI) wakiltar cibiyar tarayyar jamus ce ta allurar rigakafi da Biomedicine, da ke da alhakin cibiyar bincike kan magunguna da kuma hukumar tsara dokoki. PEI ita ma babbar hukuma ce ta tarayya da ke ba da rahoto ga Ma’aikatar Lafiya ta Tarayya, cibiyar hadin gwiwa don tabbatar da ingancin kayayyakin jinyar WHO da kayan bincike na vitro. An lakafta shi ne bayan darektan kafa shi, masanin rigakafi da kuma wanda ya sami lambar yabo ta Nobel, Paul Ehrlich.

02. Game da saurin gwajin antigen
Me yasa muke buƙatar gwajin antigen mai sauri?
Antigen yana nufin wani abu wanda zai iya samar da kwayoyi, shine duk wani abu wanda zai iya haifar da martani na garkuwar jiki. Ana iya amfani da gwajin antigen a farkon matakin cutar (bayan farawar alamomin cikin kwanaki 1-5 ko ma a lokacin shiryawar) don samun sakamako mai kyau. Hanyar gano antigen ta fi dacewa da bincike na lokaci-lokaci game da shari'ar da ake zargi da kamuwa da cutar coronavirus mai girma kuma yana da matukar tasiri ga yankunan da ke fama da cutar. Dangane da mummunan yanayi mai rikitarwa, WHO, SAMUN da sauran ƙungiyoyi na duniya da yawa suna inganta gano Antigen azaman ingantattun hanyoyin.
Ciki har da Burtaniya, Faransa, Slovakia, Slovenia, Georgia, da sauran ƙasashe da yawa sun riga sun fara siye da yin gwajin Antigen Rapid a cikin manyan wuraren tattara jama'a.
COVID-19 Antigen Gaggawar Gwaji (Gwanin Colloidal)

sd

03.
COVID-19 Antigen Gaggawar Gwaji (Gwanin Colloidal)
nasopharyngeal swab a matsayin samfurin
Babban ƙwarewa & keɓancewa

dasd

Shortan gajeren lokacin taga, gano cututtuka a farkon matakin da lokacin shiryawa, masu amfani don binciken farko. Binciken farko ya kawo ingantaccen magani.
Ya dace da al'amuran daban-daban: cibiyoyin da aka tsara (kamar asibitoci); dawo da aiki da makaranta, ci gaba da lura da sababbin yanayin yanayin jijiyoyin jiki, da sauransu;
Hanyar-mataki ɗaya, mai sauƙin aiki, rage ganowar da aka ɓace da gano kuskuren da kuskuren aiki ya haifar;
Bayar da cikakken saitin abubuwan reagent da kayan masarufin da ake buƙata don gwaji; ba a buƙatar kayan aiki;
Aiki mai sauri, sakamako a cikin minti 10-15;
Ma'ajin zafin jiki: 2 ~ 30 ℃, babu buƙatar jigilar kayan sanyi;
Zabin bayani dalla-dalla: 25 servings / box, 1 serving / box;
Mahara hadin halaye, yarda da OEM / ODM

04. Samu cancantar:
Takaddun shaida na CE, fitaccen fitowar ma'aikatar kasuwanci

b1
b2
b3
b4

An jera a cikin EU coronavirus bayani na bayani bayani na bayani, wanda WHO-FIND Innovation Foundation ta jera, kuma ya wuce binciken PEI na Jamus,

j1
j2
j3

Takaddar rajista ta Jamus da Italiya

dali1
dali2

Post lokaci: Mar-12-2021